ScholarIQanswers from OpenAlex

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure

PaperCitations, authors & open-access status

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure have?

ScholarIQcitation count

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure has 180 citations in the OpenAlex counts ScholarIQ stores.

When was Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure published?

ScholarIQyear

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure has 2007 year in the ScholarIQ index.

What is the open-access status of Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure?

ScholarIQoa status

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure has closed oa status in the ScholarIQ index.

What is the DOI of Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure?

ScholarIQdoi

The DOI for Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure is on the source record.

What is the PMID of Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure?

ScholarIQpmid

The PMID for Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure is on the source record.

What is the OpenAlex record for Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure?

ScholarIQopenalex

The OpenAlex for Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial